GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for bowman-birk type proteinase inhibitor C1 (C0HLT4)

Analyse AlphaFold monomer V2.0 prediction for bowman-birk type proteinase inhibitor C1… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
C0HLT4
Type
protein
Length
60 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x4d10233e8d7916EAcA13bcc0a521cCa504C4dDE7
Molecule
Bowman-birk type proteinase inhibitor C1
UniProt
C0HLT4

Structure

1 distinct chain · 0% helix, 42% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABowman-birk type proteinase inhibitor C1protein600% helix, 42% strandC0HLT4

Modifications

Observed in the structure: 5 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.